Cochrane Abstracts
Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Pergolide Versus Bromocriptine for Levodopa-induced Complications in Parkinson's Disease: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431447/all/Pergolide_versus_bromocriptine_for_levodopa_induced_complications_in_Parkinson's_disease:_Cochrane_systematic_review. Accessed 01 August 2021.
Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431447/all/Pergolide_versus_bromocriptine_for_levodopa_induced_complications_in_Parkinson's_disease:_Cochrane_systematic_review. Accessed August 1, 2021.
Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431447/all/Pergolide_versus_bromocriptine_for_levodopa_induced_complications_in_Parkinson's_disease:_Cochrane_systematic_review
Pergolide Versus Bromocriptine for Levodopa-induced Complications in Parkinson's Disease: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2021 August 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431447/all/Pergolide_versus_bromocriptine_for_levodopa_induced_complications_in_Parkinson's_disease:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
ID - 431447
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431447/all/Pergolide_versus_bromocriptine_for_levodopa_induced_complications_in_Parkinson's_disease:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
